JP2013508296A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013508296A5 JP2013508296A5 JP2012534391A JP2012534391A JP2013508296A5 JP 2013508296 A5 JP2013508296 A5 JP 2013508296A5 JP 2012534391 A JP2012534391 A JP 2012534391A JP 2012534391 A JP2012534391 A JP 2012534391A JP 2013508296 A5 JP2013508296 A5 JP 2013508296A5
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- emulsion
- omega
- composition
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 74
- 239000000839 emulsion Substances 0.000 claims 51
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 41
- 229940012843 omega-3 fatty acid Drugs 0.000 claims 39
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 35
- 239000003921 oil Substances 0.000 claims 34
- 239000012141 concentrate Substances 0.000 claims 21
- 239000004094 surface-active agent Substances 0.000 claims 15
- 238000009472 formulation Methods 0.000 claims 8
- 235000021588 free fatty acids Nutrition 0.000 claims 8
- 239000006184 cosolvent Substances 0.000 claims 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 6
- 150000002148 esters Chemical class 0.000 claims 6
- 239000007788 liquid Substances 0.000 claims 6
- -1 polyoxyethylene Polymers 0.000 claims 6
- 239000000047 product Substances 0.000 claims 6
- 239000004359 castor oil Substances 0.000 claims 4
- 235000019438 castor oil Nutrition 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 4
- 239000006014 omega-3 oil Substances 0.000 claims 4
- 239000008346 aqueous phase Substances 0.000 claims 3
- 235000015872 dietary supplement Nutrition 0.000 claims 3
- 235000016709 nutrition Nutrition 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims 3
- 229940127557 pharmaceutical product Drugs 0.000 claims 3
- 210000002966 serum Anatomy 0.000 claims 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 2
- 239000005642 Oleic acid Substances 0.000 claims 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims 2
- 238000010521 absorption reaction Methods 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 208000029078 coronary artery disease Diseases 0.000 claims 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims 2
- 230000035622 drinking Effects 0.000 claims 2
- 229930195729 fatty acid Natural products 0.000 claims 2
- 239000000194 fatty acid Substances 0.000 claims 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 2
- 229920000053 polysorbate 80 Polymers 0.000 claims 2
- 150000003138 primary alcohols Chemical class 0.000 claims 2
- 150000003333 secondary alcohols Chemical class 0.000 claims 2
- 150000003509 tertiary alcohols Chemical class 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 208000035150 Hypercholesterolemia Diseases 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- 235000009421 Myristica fragrans Nutrition 0.000 claims 1
- 230000003143 atherosclerotic effect Effects 0.000 claims 1
- 230000007211 cardiovascular event Effects 0.000 claims 1
- 239000007903 gelatin capsule Substances 0.000 claims 1
- 239000007902 hard capsule Substances 0.000 claims 1
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 1
- 239000001115 mace Substances 0.000 claims 1
- 239000012071 phase Substances 0.000 claims 1
- 238000004094 preconcentration Methods 0.000 claims 1
- 239000007901 soft capsule Substances 0.000 claims 1
- 208000019553 vascular disease Diseases 0.000 claims 1
- 230000006441 vascular event Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25231009P | 2009-10-16 | 2009-10-16 | |
| US61/252,310 | 2009-10-16 | ||
| US26769709P | 2009-12-08 | 2009-12-08 | |
| US61/267,697 | 2009-12-08 | ||
| PCT/US2010/052840 WO2011047259A1 (en) | 2009-10-16 | 2010-10-15 | Compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016113002A Division JP2016222672A (ja) | 2009-10-16 | 2016-06-06 | 組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013508296A JP2013508296A (ja) | 2013-03-07 |
| JP2013508296A5 true JP2013508296A5 (enExample) | 2013-12-05 |
| JP5951489B2 JP5951489B2 (ja) | 2016-07-13 |
Family
ID=43876577
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012534391A Active JP5951489B2 (ja) | 2009-10-16 | 2010-10-15 | 組成物 |
| JP2016113002A Pending JP2016222672A (ja) | 2009-10-16 | 2016-06-06 | 組成物 |
| JP2017201136A Active JP6430608B2 (ja) | 2009-10-16 | 2017-10-17 | 組成物 |
| JP2018204583A Active JP6728303B2 (ja) | 2009-10-16 | 2018-10-31 | 組成物 |
| JP2020112593A Active JP7055840B2 (ja) | 2009-10-16 | 2020-06-30 | 組成物 |
| JP2022063232A Pending JP2022095815A (ja) | 2009-10-16 | 2022-04-06 | 組成物 |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016113002A Pending JP2016222672A (ja) | 2009-10-16 | 2016-06-06 | 組成物 |
| JP2017201136A Active JP6430608B2 (ja) | 2009-10-16 | 2017-10-17 | 組成物 |
| JP2018204583A Active JP6728303B2 (ja) | 2009-10-16 | 2018-10-31 | 組成物 |
| JP2020112593A Active JP7055840B2 (ja) | 2009-10-16 | 2020-06-30 | 組成物 |
| JP2022063232A Pending JP2022095815A (ja) | 2009-10-16 | 2022-04-06 | 組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US9717703B2 (enExample) |
| EP (1) | EP2488022B1 (enExample) |
| JP (6) | JP5951489B2 (enExample) |
| ES (1) | ES2661812T3 (enExample) |
| WO (1) | WO2011047259A1 (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5924834B2 (ja) | 2008-09-02 | 2016-05-25 | アマリン ファーマシューティカルズ アイルランド リミテッド | エイコサペンタエン酸およびニコチン酸を含む製薬組成物ならびにこの製薬組成物を用いる方法 |
| ES2979118T3 (es) | 2009-03-09 | 2024-09-24 | Basf As | Composiciones que comprenden una mezcla de aceites de ácidos grasos y un ácido graso libre, y procedimientos y usos de las mismas |
| HUE034941T2 (en) | 2009-04-29 | 2018-03-28 | Amarin Pharmaceuticals Ie Ltd | Stable pharmaceutical composition and methods of using same |
| NZ734905A (en) | 2009-04-29 | 2019-05-31 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| EP3318255B1 (en) | 2009-06-15 | 2021-03-10 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for treating stroke in a subject on concomitant statin therapy |
| MX2012003555A (es) | 2009-09-23 | 2012-07-03 | Amarin Corp Plc | Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma. |
| JP6116905B2 (ja) * | 2009-10-23 | 2017-04-19 | プロノヴァ・バイオファーマ・ノルゲ・アーエスＰｒｏｎｏｖａ ＢｉｏＰｈａｒｍａ Ｎｏｒｇｅ ＡＳ | 脂肪酸油混合物の被覆型カプセル剤および錠剤 |
| JP5920890B2 (ja) | 2010-01-19 | 2016-05-18 | ディーエスエム アイピー アセッツ ビー．ブイ． | エイコサペンタエン酸生成微生物、脂肪酸組成物、ならびにそれらを作る方法およびそれらの使用 |
| US9585837B2 (en) * | 2010-04-09 | 2017-03-07 | Dsm Ip Assets B.V. | Thermally stable oil-in-water emulsions containing an oil that contains polyunsaturated fatty acids |
| US20140004186A1 (en) * | 2010-09-08 | 2014-01-02 | Pronova Biopharma Norge As | Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin |
| EP2613767A4 (en) * | 2010-09-08 | 2014-03-19 | Pronova Biopharma Norge As | Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin |
| US8557593B2 (en) | 2010-09-16 | 2013-10-15 | Quest Diagnostics Investments Incorporated | Mass spectrometric determination of eicosapentaenoic acid and docosahexaenoic acid |
| WO2012074930A2 (en) | 2010-11-29 | 2012-06-07 | Amarin Pharma, Inc. | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
| US11712429B2 (en) | 2010-11-29 | 2023-08-01 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
| DE102011050493A1 (de) | 2011-05-19 | 2012-11-22 | Ludwig-Maximilians-Universität München | Vorrichtung und Verfahren zur Detektion der Auslenkung elastischer Elemente |
| EP2952183A1 (en) * | 2011-07-21 | 2015-12-09 | DSM IP Assets B.V. | Fatty acid compositions |
| US20130131170A1 (en) | 2011-11-07 | 2013-05-23 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
| US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
| US9827219B2 (en) | 2012-01-06 | 2017-11-28 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject |
| WO2013148136A1 (en) | 2012-03-30 | 2013-10-03 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions |
| US9480651B2 (en) | 2012-03-30 | 2016-11-01 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms |
| US10898458B2 (en) | 2012-03-30 | 2021-01-26 | Micelle Biopharma, Inc. | Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states |
| US20160228397A1 (en) | 2012-03-30 | 2016-08-11 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions |
| MX392694B (es) | 2012-06-29 | 2025-03-24 | Amarin Pharmaceuticals Ie Ltd | Metodos para reducir riesgo de evento cardiovascular en sujeto con terapia con estatina |
| WO2014074552A2 (en) | 2012-11-06 | 2014-05-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy |
| US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
| US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
| US9624492B2 (en) | 2013-02-13 | 2017-04-18 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
| US20140271841A1 (en) | 2013-03-15 | 2014-09-18 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin |
| US10966968B2 (en) | 2013-06-06 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
| CN110840874A (zh) | 2013-07-18 | 2020-02-28 | 持田制药株式会社 | ω-3脂肪酸的自乳化组合物 |
| WO2015008849A1 (ja) * | 2013-07-18 | 2015-01-22 | 持田製薬株式会社 | ω３脂肪酸の自己乳化組成物 |
| WO2015011724A2 (en) * | 2013-07-22 | 2015-01-29 | Kms Health Center Pvt Ltd | A novel omega -3 fatty acid composition with a plant extract |
| US20150065572A1 (en) | 2013-09-04 | 2015-03-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing prostate cancer |
| US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
| US10561631B2 (en) | 2014-06-11 | 2020-02-18 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
| WO2015195662A1 (en) | 2014-06-16 | 2015-12-23 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids |
| KR102488648B1 (ko) * | 2015-01-21 | 2023-01-12 | 모치다 세이야쿠 가부시키가이샤 | ω3 지방산의 자기 유화 조성물 |
| US10406130B2 (en) | 2016-03-15 | 2019-09-10 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
| AR105674A1 (es) * | 2016-08-11 | 2017-10-25 | Consejo Nac De Investigaciones Científicas Y Técnicas (Conicet) | Una nanoemulsión comestible de aceite de chía |
| US11241408B2 (en) * | 2016-08-12 | 2022-02-08 | Pharmako Biotechnologies Pty Limited | Omega-3 compositions and methods relating thereto |
| WO2018213663A1 (en) | 2017-05-19 | 2018-11-22 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject having reduced kidney function |
| US11058661B2 (en) | 2018-03-02 | 2021-07-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L |
| JP7020756B2 (ja) | 2018-09-24 | 2022-02-16 | アマリン ファーマシューティカルズ アイルランド リミテッド | 対象の心血管イベントのリスクを低減する方法 |
| IL268457B (en) * | 2019-08-04 | 2022-05-01 | Omega 3 Galilee Ltd | Oil- suspension of edible solids and methods of preparing the same |
| WO2021097120A1 (en) | 2019-11-12 | 2021-05-20 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of cardiovascular events in a subject with atrial fibrillation and/or atrial flutter |
| US20230113738A1 (en) * | 2020-03-06 | 2023-04-13 | Optimega Llc | Fatty acid compositions for enteral use |
| KR102736482B1 (ko) * | 2020-06-26 | 2024-11-28 | 건국대학교 산학협력단 | 나노에멀젼이 포함된 육류 제품 및 이의 제조방법 |
| JP2021008518A (ja) * | 2020-10-21 | 2021-01-28 | 持田製薬株式会社 | ω３脂肪酸の自己乳化組成物 |
| WO2022225896A1 (en) | 2021-04-21 | 2022-10-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of heart failure |
| IL289782B (en) * | 2022-01-12 | 2022-07-01 | Omega 3 Galilee Ltd | Oil- suspension of edible solids and methods of preparing the same |
Family Cites Families (94)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4096258A (en) | 1974-12-16 | 1978-06-20 | Par-Way Mfg. Co. | Method for preparing a stable clear liquid release agent |
| US4192898A (en) | 1975-10-10 | 1980-03-11 | Par-Way Mfg Co. | Stable clear liquid release agent and method for preparation |
| CA1282326C (en) | 1984-12-14 | 1991-04-02 | Paul J. Jarosz | Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient |
| US4665098A (en) | 1985-03-28 | 1987-05-12 | Mcneilab, Inc. | Pharmaceutical composition of N-(4-hydroxyphenyl) retinamide having increased bioavailability |
| JPS63101320A (ja) | 1986-10-17 | 1988-05-06 | Dainippon Pharmaceut Co Ltd | バルプロ酸カルシウム製剤 |
| NZ224497A (en) | 1987-05-18 | 1990-04-26 | Janssen Pharmaceutica Nv | Pharmaceutical composition comprising flunarizine |
| GB8819110D0 (en) | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
| US5532002A (en) | 1989-08-17 | 1996-07-02 | Cortecs Limited | Gelatin pharmaceutical formulations |
| EP0489898A4 (en) | 1990-06-01 | 1993-06-09 | Research Corporation Technologies, Inc. | Self-emulsifying glasses |
| US5407683A (en) | 1990-06-01 | 1995-04-18 | Research Corporation Technologies, Inc. | Pharmaceutical solutions and emulsions containing taxol |
| ATE147620T1 (de) | 1991-07-26 | 1997-02-15 | Smithkline Beecham Corp | W/o mikroemulsionen |
| EP0573978B1 (en) | 1992-06-12 | 1999-04-21 | Kao Corporation | Bath additive composition comprising surfactant-containing seamless capsules and method for producing the capsules. |
| DK88692D0 (da) * | 1992-07-06 | 1992-07-06 | Danochemo As | Fremgangsmaade til fremstilling af mikrokapsler |
| JPH0649479A (ja) * | 1992-07-28 | 1994-02-22 | Maruha Corp | ω−３不飽和脂肪酸系化合物の安定化法 |
| JP3405746B2 (ja) | 1992-10-28 | 2003-05-12 | フロイント産業株式会社 | シームレスカプセルの製造方法 |
| JPH06298642A (ja) * | 1993-04-14 | 1994-10-25 | Japan Tobacco Inc | 高度不飽和脂肪酸含有ｏ／ｗ型乳剤及びその酸化防止方法 |
| US5567592A (en) | 1994-02-02 | 1996-10-22 | Regents Of The University Of California | Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal |
| GB9405041D0 (en) | 1994-03-15 | 1994-04-27 | Smithkline Beecham Plc | Novel process |
| FR2729307B1 (fr) | 1995-01-18 | 1997-04-18 | Seppic Sa | Utilisation d'esters d'acides gras ethoxyles comme composants auto-emulsionnables notamment utiles pour la preparation de produits de traitement phytosanitaires ou de medicaments a usage veterinaire ou humain |
| US5965160A (en) | 1995-04-24 | 1999-10-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Self-emulsifiable formulation producing an oil-in-water emulsion |
| JP3759986B2 (ja) | 1995-12-07 | 2006-03-29 | フロイント産業株式会社 | シームレスカプセルおよびその製造方法 |
| NZ502567A (en) | 1997-07-29 | 2002-03-28 | Upjohn Co | Self-emulsifying formulation for lipophilic compounds containing a pyranone and a mixture of monoglycerides and diglycerides |
| SI0989851T1 (en) | 1997-07-29 | 2003-04-30 | Pharmacia & Upjohn Company | Self-emulsifying formulation for acidic lipophilic compounds |
| US5972182A (en) | 1997-12-05 | 1999-10-26 | Ceramphysics, Inc. | Electrode composition and application method for oxygen generators |
| JP4761093B2 (ja) * | 1997-12-10 | 2011-08-31 | シクロスポリン セラポイティクス リミテッド | オメガ−３脂肪酸油を含む医薬組成物 |
| US6979456B1 (en) | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
| WO1999056727A2 (en) | 1998-05-07 | 1999-11-11 | Elan Corporation, Plc | Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems |
| US20030235595A1 (en) | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent |
| AU7638300A (en) | 1999-10-20 | 2001-04-30 | Vesifact Ag | Microemulsion preconcentrates and microemulsions |
| JP2001152179A (ja) | 1999-11-30 | 2001-06-05 | Takasago Internatl Corp | 香味持続型粉末香料の調製方法 |
| US20050037073A1 (en) | 2000-01-13 | 2005-02-17 | Alpharx Inc. | Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof |
| US20020102301A1 (en) | 2000-01-13 | 2002-08-01 | Joseph Schwarz | Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof |
| SE0000774D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
| SE0000773D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
| KR100393478B1 (ko) | 2000-03-29 | 2003-08-06 | 주식회사종근당 | 자가유화 매트릭스형 경점막·경피흡수제제 |
| MXPA03000720A (es) | 2000-07-24 | 2004-11-01 | Upjohn Co | Sistemas auto-emulsificantes de suministro de medicamentos para medicamentos lipofilicos extremadamente insolubles en agua. |
| US6667064B2 (en) | 2000-08-30 | 2003-12-23 | Pilot Therapeutics, Inc. | Composition and method for treatment of hypertriglyceridemia |
| MXPA03004818A (es) | 2000-11-29 | 2003-09-10 | Smithkline Beecham Corp | Composicion conteniendo estatinas y calcio para salud cardiovascular mejorada. |
| KR100426346B1 (ko) | 2000-11-30 | 2004-04-08 | 한국화학연구원 | 자가미세유화형 약물전달시스템을 이용한 고지혈증치료용약제 조성물 |
| FR2818905A1 (fr) | 2000-12-28 | 2002-07-05 | Cll Pharma | Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile |
| GB0101198D0 (en) | 2001-01-17 | 2001-02-28 | Scherer Technologies Inc R P | Ingestible compositions containing an odoriferous oil |
| WO2002085328A2 (de) * | 2001-02-11 | 2002-10-31 | Aquanova German Solubilisate Technologies (Agt) Gmbh | Verfahren zur herstellung eines wirkstoffkonzentrats sowie wirkstoffkonzentrat |
| US20030105141A1 (en) | 2001-04-17 | 2003-06-05 | Ping Gao | Finely self-emulsifiable pharmaceutical composition |
| AUPR573001A0 (en) | 2001-06-15 | 2001-07-12 | Glaxo Wellcome Australia Ltd | Lymphatic drug delivery system |
| US20040018248A1 (en) | 2001-11-29 | 2004-01-29 | Adrianne Bendich | Composition containing statins and calcium for improved cardiovascular health |
| NO20021592D0 (no) | 2002-04-04 | 2002-04-04 | Fmc Biopolymer As | Polysakkaridkapsler og fremgangsmåte ved fremstilling derav |
| IL164163A0 (en) | 2002-04-09 | 2005-12-18 | Pharmacia Corp | Process for preparing a finely self-emulsifiable pharmaceutical composition |
| US7182950B2 (en) | 2002-06-12 | 2007-02-27 | Nutralease Ltd. | Nano-sized self-assembled liquid dilutable vehicles |
| AU2003238264B2 (en) * | 2002-06-18 | 2009-05-21 | Dsm Ip Assets B.V. | Stable emulsions of oils in aqueous solutions and methods for producing same |
| JP4417039B2 (ja) | 2002-06-28 | 2010-02-17 | 太陽化学株式会社 | 水中油滴型乳化組成物 |
| CN1166368C (zh) * | 2003-02-26 | 2004-09-15 | 刘威 | 海狗油脂肪乳注射液、其制备方法及其在制备静脉注射剂中的应用 |
| US20040185068A1 (en) | 2003-03-18 | 2004-09-23 | Zhi-Jian Yu | Self-emulsifying compositions, methods of use and preparation |
| US20060251685A1 (en) * | 2003-03-18 | 2006-11-09 | Zhi-Jian Yu | Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye |
| US20050196370A1 (en) | 2003-03-18 | 2005-09-08 | Zhi-Jian Yu | Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye |
| US7687066B2 (en) | 2003-05-09 | 2010-03-30 | The Nisshin Oillio Group, Ltd. | Self emulsifying oily liquid cosmetic |
| WO2005037250A1 (en) | 2003-10-17 | 2005-04-28 | Amylin Pharmaceuticals, Inc. | Self emulsifying drug delivery systems for hydrophobic therapeutic compounds |
| WO2005037251A1 (en) | 2003-10-17 | 2005-04-28 | Amylin Pharmaceuticals, Inc. | Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds |
| ES2235642B2 (es) | 2003-12-18 | 2006-03-01 | Gat Formulation Gmbh | Proceso de multi-microencapsulacion continuo para la mejora de la estabilidad y almacenamiento de ingredientes biologicamente activos. |
| US7022713B2 (en) | 2004-02-19 | 2006-04-04 | Kowa Co., Ltd. | Hyperlipemia therapeutic agent |
| US20050238675A1 (en) | 2004-04-26 | 2005-10-27 | Wenjie Li | Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications |
| FR2873585B1 (fr) | 2004-07-27 | 2006-11-17 | Aventis Pharma Sa | Nouvelles formulations galeniques de principes actifs |
| CN1870906A (zh) | 2004-07-22 | 2006-11-29 | 德国阿奎诺瓦增溶技术有限公司 | 醚油和其他物质的溶解物 |
| US7642287B2 (en) | 2004-08-06 | 2010-01-05 | Transform Pharmaceuticals, Inc. | Statin pharmaceutical compositions and related methods of treatment |
| JP4943849B2 (ja) | 2004-08-18 | 2012-05-30 | 持田製薬株式会社 | ゼリー組成物 |
| US20060051462A1 (en) | 2004-09-03 | 2006-03-09 | Wang Jimmy X | Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients |
| US20080311207A1 (en) | 2004-09-08 | 2008-12-18 | Manoj Varshney | Micelles and Nanoemulsions for Preventive and Reactive Treatment of Atherosclerosis |
| US20060088574A1 (en) | 2004-10-25 | 2006-04-27 | Manning Paul B | Nutritional supplements |
| US20060083824A1 (en) | 2004-10-20 | 2006-04-20 | Pbm Products Llc | Nutritional supplements for glucose intolerant individuals |
| WO2006062748A2 (en) | 2004-12-06 | 2006-06-15 | Reliant Pharmaceuticals, Inc. | Omega-3 fatty acids and dyslipidemic agent for lipid therapy |
| US8637070B2 (en) | 2005-02-09 | 2014-01-28 | Santen Pharmaceutical Co., Ltd. | Rapamycin formulations and methods of their use |
| EP1861087A4 (en) | 2005-03-08 | 2010-02-10 | Reliant Pharmaceuticals Inc | TREATMENT WITH STATINE AND OMEGA-3-FATTY ACID AS A COMBINATION PRODUCT THEREOF |
| CN1853728A (zh) | 2005-04-19 | 2006-11-01 | 上海天博生物科技有限公司 | 一种改善药物或营养物口服吸收的方法、配方及其应用 |
| US20060292217A1 (en) | 2005-06-03 | 2006-12-28 | Schmidt Robbin D | Nutritional supplement and soft gelatin capsule delivery system |
| US20070031538A1 (en) | 2005-07-13 | 2007-02-08 | Gul Konuklar | Liquid nutritional compositions containing n-3 polyunsaturated fatty acids |
| US20070036873A1 (en) | 2005-07-27 | 2007-02-15 | Shibnath Ghosal | Method of treatment or management of stress |
| US9743680B2 (en) | 2005-10-14 | 2017-08-29 | Wild Flavors, Inc. | Microemulsions for use in food and beverage products |
| ES2348743T3 (es) | 2005-11-22 | 2010-12-13 | Nestec S.A. | Emulsion aceite-en-agua y su uso para administrar una funcionalidad. |
| US20090012157A1 (en) | 2006-02-06 | 2009-01-08 | Sears Barry D | Sesamol Derivatives as Novel Inhibitors of Arachidonic Acid Formation |
| JP5372525B2 (ja) | 2006-03-03 | 2013-12-18 | エフ エム シー コーポレーション | カプセルの製造方法および該製造方法により製造されるカプセル |
| MY153288A (en) | 2006-06-28 | 2015-01-29 | Hovid Berhad | An effective pharmaceutical carrier for poorly bioavailable drugs |
| US20080058418A1 (en) * | 2006-09-06 | 2008-03-06 | The Coca-Cola Company | Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion |
| KR100835250B1 (ko) | 2006-09-07 | 2008-06-09 | 주식회사 바이오랜드 | 자기유화 전달체 및 이의 제조방법 |
| JP2008178341A (ja) | 2007-01-24 | 2008-08-07 | Taiyo Kagaku Co Ltd | 多価不飽和脂肪酸含有組成物 |
| WO2008101344A1 (en) * | 2007-02-22 | 2008-08-28 | Peter Tomlinson | Soluble bioactive lipophilic compounds compositions |
| WO2008113177A1 (en) | 2007-03-20 | 2008-09-25 | Centre De Recherche Sur Les Biotechnologies Marines | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof |
| JP5135852B2 (ja) | 2007-03-30 | 2013-02-06 | 日油株式会社 | 可溶化用組成物 |
| AR060847A1 (es) | 2007-05-03 | 2008-07-16 | Spannagel Lucia Antonia | Formulacion a base de calendula, aloe y centella. |
| EP2142015A2 (de) | 2007-05-09 | 2010-01-13 | Mivital AG | Emulsionsvorkonzentrate sowie micellare formulierungen enthaltend wurzelharz |
| BRPI0909187A2 (pt) | 2008-03-20 | 2015-08-04 | Virun Inc | Emulsões incluindo tocoferol de derivados de peg |
| MX2010010214A (es) | 2008-03-20 | 2010-12-21 | Virun Inc | Derivados de vitamina e y sus usos. |
| WO2010008475A2 (en) | 2008-06-23 | 2010-01-21 | Virun, Inc. | Compositions containing nono-polar compounds |
| JP2010155799A (ja) * | 2008-12-26 | 2010-07-15 | Fujifilm Corp | 粉末組成物及びそれを含む食品 |
| ES2979118T3 (es) * | 2009-03-09 | 2024-09-24 | Basf As | Composiciones que comprenden una mezcla de aceites de ácidos grasos y un ácido graso libre, y procedimientos y usos de las mismas |
| JP6116905B2 (ja) | 2009-10-23 | 2017-04-19 | プロノヴァ・バイオファーマ・ノルゲ・アーエスＰｒｏｎｏｖａ ＢｉｏＰｈａｒｍａ Ｎｏｒｇｅ ＡＳ | 脂肪酸油混合物の被覆型カプセル剤および錠剤 |
-
2010
- 2010-10-15 WO PCT/US2010/052840 patent/WO2011047259A1/en not_active Ceased
- 2010-10-15 JP JP2012534391A patent/JP5951489B2/ja active Active
- 2010-10-15 US US13/502,214 patent/US9717703B2/en active Active
- 2010-10-15 EP EP10824162.1A patent/EP2488022B1/en active Active
- 2010-10-15 ES ES10824162.1T patent/ES2661812T3/es active Active
-
2016
- 2016-06-06 JP JP2016113002A patent/JP2016222672A/ja active Pending
-
2017
- 2017-06-23 US US15/631,104 patent/US10668038B2/en active Active
- 2017-10-17 JP JP2017201136A patent/JP6430608B2/ja active Active
-
2018
- 2018-10-31 JP JP2018204583A patent/JP6728303B2/ja active Active
-
2020
- 2020-04-20 US US16/852,603 patent/US20200246299A1/en not_active Abandoned
- 2020-06-30 JP JP2020112593A patent/JP7055840B2/ja active Active
-
2022
- 2022-04-06 JP JP2022063232A patent/JP2022095815A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013508296A5 (enExample) | ||
| ES2881885T3 (es) | Composiciones que comprenden una mezcla de aceites de ácidos grasos que comprende EPA y DHA en forma de ácido libre y un tensioactivo, y procedimientos y usos de las mismas | |
| EP3763364B1 (en) | Self-emulsifying composition of omega-3 fatty acid | |
| JP2015520235A5 (enExample) | ||
| CN104187627B (zh) | 一种降血脂组合物及其在制备具有降血脂功能的保健食品中的应用 | |
| CN105120842B (zh) | 包含脂质化合物、甘油三酯和表面活性剂的组合物以及使用它们的方法 | |
| UA102478C2 (en) | Capsule composition | |
| JP6276433B2 (ja) | マイクロエマルション前濃縮物及びマイクロエマルション、並びにその調製工程 | |
| RU2015102597A (ru) | Липидные композиции рацекадотрила | |
| EP2214653B1 (en) | Pharmaceutical compositions containing statins and omega-3 fatty acids derivatives and their solid formulations for oral use | |
| JP2020182497A5 (enExample) | ||
| RU2007137182A (ru) | Микроэмульсии соединений, связывающихся с каннабиноидными рецепторами | |
| JP2008532967A5 (enExample) | ||
| JP2007519603A (ja) | 血管保護物質の組合せおよびそれらを含む製剤 | |
| WO2020094736A1 (en) | Lipidic solutions of nsaids | |
| JP5847475B2 (ja) | 油脂含有組成物、及びそれを含む経口製剤 | |
| US20230218560A1 (en) | Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof | |
| JPH10330250A (ja) | メナテトレノン油性製剤 | |
| JP6887520B2 (ja) | 経口医薬組成物 | |
| JP2021084895A (ja) | ω３脂肪酸の自己乳化製剤 | |
| JP2006248928A (ja) | メナテトレノン含有医薬組成物 | |
| RU2017145265A (ru) | Фармацевтические композиции, содержащие epa и сердечно-сосудистое средство, и способы их применения | |
| BR102017007556A2 (pt) | Composições farmacêuticas a base de cocos nucifera l. compreendendo sistema de liberação controlada de fármaco do tipo smedds com indicação de uso tópico e oral na odontologia | |
| TW201311294A (zh) | 含脂肪酸油混合物、界面活性劑與司它汀（ｓｔａｔｉｎ）的組成物 |